Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€182.40

€182.40

7.790%
12.8
7.790%
€180.00

€180.00

 
Latest predictions
€180.00
06.01.21
buy
€110.00
23.12.20
-
22.12.20
buy
-
16.11.20
buy
€170.00
05.10.20
buy
€188.00
01.09.20
buy
Your prediction

Shop Apotheke Europe NV Stock

Shop Apotheke Europe NV dominated the market today, gaining €12.80 (7.790%).
With 14 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
On the other hand, the target price of €180.00 is below the current price of €182.40 for Shop Apotheke Europe NV, so the potential is actually -1.316%.
So far the community has only identified positive things for Shop Apotheke Europe NV stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".

Pros and Cons of Shop Apotheke Europe NV in the next few years

Pros
3
Could be very worthwhile Investment >20% year
2
Well known brand
2
Very Future proof/growth oriented business model
Cons
0
-

Performance of Shop Apotheke Europe NV vs. its peers

Security Change (%) 1w 1m 1y YTD 3y 5y
Shop Apotheke Europe NV 7.790% 11.355% 33.529% 317.391% 24.082% 300.879% -
Overstock.com -2.890% 2.579% -1.700% 618.530% 18.349% - -
Liberty Tripadv. Hldgs A 1.120% -5.759% 16.883% - 9.091% - -
Nic Inc. 4.350% 9.091% 15.385% 20.000% 15.385% 77.778% 44.404%

Comments

Buy Shop Apotheke Europe NV

Sell Shop Apotheke Europe NV

Buy Shop Apotheke Europe NV

Other discussions about Shop Apotheke Europe NV Stock

Trading Shop Apotheke Europe NV

Trading Shop Apotheke Europe NV

New thread Forum

News

DGAP-News: SHOP APOTHEKE EUROPE continues its dynamic growth course and again raises its 2020 guidance.
DGAP-News: SHOP APOTHEKE EUROPE continues its dynamic growth course and again raises its 2020 guidance.
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ANNOUNCES REDEMPTION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ANNOUNCES REDEMPTION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ENDS DISCUSSIONS AND ANNOUNCES CLEAN-UP OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ENDS DISCUSSIONS AND ANNOUNCES CLEAN-UP OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
DGAP-News: SHOP APOTHEKE EUROPE grows by 39.7% in Q3.
DGAP-News: SHOP APOTHEKE EUROPE grows by 39.7% in Q3.
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V.:
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V.:
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ANNOUNCES TO START DISCUSSIONS OF A POSSIBLE EARLIER CONVERSION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
DGAP-Adhoc: SHOP APOTHEKE EUROPE N.V. ANNOUNCES TO START DISCUSSIONS OF A POSSIBLE EARLIER CONVERSION OF ITS EUR 135 MILLION 4.5% CONVERTIBLE BONDS DUE 2023.
DGAP-News: SHOP APOTHEKE EUROPE promoted to MDAX.
DGAP-News: SHOP APOTHEKE EUROPE promoted to MDAX.
DGAP-News: SHOP APOTHEKE EUROPE: 42% growth and significantly improved bottom line in Q2; adjusted Q2 EBITDA margin 2.7%.
DGAP-News: SHOP APOTHEKE EUROPE: 42% growth and significantly improved bottom line in Q2; adjusted Q2 EBITDA margin 2.7%.
DGAP-Adhoc: SHOP APOTHEKE EUROPE raises full year 2020 guidance.
DGAP-Adhoc: SHOP APOTHEKE EUROPE raises full year 2020 guidance.